fenofibric acid 135 MG Delayed Release Oral Capsule [Trilipix]
Managing this medication for someone you care for? Eleplan keeps diagnoses, medications and appointments in one plan.
Start free with EleplanClinical drug
fenofibric acid 135 MG Delayed Release Oral Capsule [Trilipix]
135 MG · Delayed Release Oral Capsule · oral
A form of fenofibric acid →
fenofibric acid 135 MG Delayed Release Oral Capsule [Trilipix] — Fibrates. Strength, form, class, interactions & more.
![fenofibric acid 135 MG Delayed Release Oral Capsule [Trilipix]](https://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=369b3e55-2c05-d879-fe7e-91296c529ae9&name=fenofibric-acid-amneal-spl-01.jpg)
Active ingredient
Classification
FibratesPeroxisome Proliferator-activated Receptor alpha Agonist
Drug interactions
Fenofibric acid has several drug interactions that may affect its efficacy and safety.
- majorCoumarin Anticoagulants — Potentiation of coumarin-type anticoagulant effect with prolongation of PT/INR
- moderateBile Acid Binding Resins — Impeded absorption of fenofibric acid
- majorImmunosuppressants — Risk of nephrotoxicity and deterioration of renal function
- majorColchicine — Risk of myopathy, including rhabdomyolysis
Source: RxNorm + openFDA + RxClass + FAERS · 2026
Look up another medication